Ophthalmic topical use of collagen cross-linking inhibitors

Details Ophthalmic topical use of collagen cross-linking inhibitors Ophthalmic topical use of collagen cross-linking inhibitors

1981-07-06

1984-04-24

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Recombinant or stably-transformed bacterium encoding one or...

A61K 31275

Patent

active

044447876

ABSTRACT:
This invention relates to the treatment of wounded ocular tissue by the topical application of collagen cross-linking inhibitors to the tissue in order to reduce the cross-linking of collagen fibrils in the wounded tissue.

REFERENCES:
patent: 2742491 (1958-04-01), Selilard et al.
Am. Surg., 165:442 (1967)-Furlow et al.
Clin. Pharmacal. Ther., 8:593 (1967)-Keiser et al.
Ann. Surg., 178:277 (1973)-Madden et al.
Current Eye Res. 1:77 (1981)-Moorhead.
Surgery, 66:215 (1969)-Peacock et al.
J. Urol., 115:673 (1976)-Singh et al.
Wellcome Trends, Apr. -Jun. (1981)-pp. 5-6.
Chem. Abst. 77, 122,003(p) (1972)-Chansouria et al.
Chem. Abst. 78, 66682(z) (1973)-Haney et al.
Chem. Abst. 90, 66806(g) (1979)-Arem et al.
Chem. Abst. 92, 486(n) (1980)-Arem et al.

Affiliated with

Also associated with

Rating

Ophthalmic topical use of collagen cross-linking inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ophthalmic topical use of collagen cross-linking inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic topical use of collagen cross-linking inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-115561